Welcome to our dedicated page for GLOBE LIFE SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
Globe Life Inc. (GL) – Form 144 filing
An undisclosed affiliate has notified the SEC of an intention to sell 15,000 common shares via Apex Clearing on or about 25 Jul 2025. At an aggregate market value of $1.97 million, the indicated price is roughly $131.5 per share. The shares were obtained through a stock-option exercise on 26 Feb 2020 and equal just 0.019 % of Globe Life’s 80.8 million shares outstanding.
Rule 144 filings serve as advance notice; the sale may or may not occur and no immediate cash proceeds accrue to the company. Given the limited size relative to float and the absence of new operational disclosures, the transaction is viewed as a routine insider liquidity move with minimal impact on Globe Life’s capital structure, earnings, or valuation.